Mipletamig-driven clinical validation of the CRIS-7 derived CD3-binding domain underpins Aptevo's expansion from hematologic to solid tumorsNew candidate APVO455 targets Nectin-4+ cancers, joins ...

National Statistician and Civil Registrar General Usec. Claire Dennis S. Mapa (2nd from left) leading the distribution of ...

Minor (under 18) without a Canadian parent applying alone. to send your application as soon as possible after you sign and date the application form We’ll return your application to you if we receive ...

Lyra Therapeutics has lost >90% of its value since announcing the failed ENLIGHTEN-1 trial. Click here to find out why I rate ...

CD19-CAR T-cell treatment is a novel option of deep B cell depletion with promising results across different rheumatologic ...

Much of the rail infrastructure is outdated, having been built over a century ago with little regard for even incremental ...

Late Sunday, as protesters against federal immigration raids clashed with law enforcement, the Los Angeles Police ...

Trump Media & Technology Group, the parent company of Truth Social, has filed a Form S-3 registration statement with the U.S. Securities ... The company stated it has no immediate plans to use the ...

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

On Tuesday, that duo combined for seven goals. Each shot was faster and harder than the last as St. Augustine, No. 3 in the NJ.com Top 20, beat No. 5 Gill St. Bernard’s, 11-5, and advanced to ...

Syracuse, N.Y. — Softball section championships are in the books and three new teams finish the season at No. 1 after winning titles. Rome Free Academy (AAA), Camden (A) and Solvay (B ...

In a pooled analysis from both trials involving 64 CRS patients with small nasal polyps, LYR-210 showed a consistent positive trend across multiple endpoints over 24 weeks. This data will inform ...